Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312129693> ?p ?o ?g. }
- W4312129693 endingPage "e005660" @default.
- W4312129693 startingPage "e005660" @default.
- W4312129693 abstract "Background Antibody-drug conjugates (ADC) are essential therapeutic options to treat solid and hematological cancers. The anti-epidermal growth factor-receptor (EGFR) antibody cetuximab (Cet) is used for the therapy of colorectal carcinoma (CRC). Anti-CRC Vδ2 cytolytic T lymphocytes can be elicited by the priming of tumor cells with the aminobisphosphonate zoledronic acid (ZA) and consequent presentation of isopentenyl pyrophosphates through butyrophilin (BTN) family members such as BTN3A1 and BTN2A1. A major drawback that impairs the targeting of ZA to CRC is the bone tropism of aminobisphosphonates. Methods The phosphoric group of ZA was linked to free amino groups of Cet in the presence of imidazole following the labeling of phosphoric groups of DNA to amino groups of proteins. The generation of Cet-ZA ADC was confirmed by matrix assisted laser desorption ionization mass spectrometry and inductively coupled plasma-mass spectrometry analysis. Thirteen CRC organoids were obtained with a chemically defined serum-free medium in Geltrex domes. Proliferation and activation of cytolytic activity against CRC organoids by Vδ2 T cells was detected with flow cytometry, crystal violet and cytotoxic probe assays and image analysis. Immunohistochemistry and quantification of BTN3A1 or BTN2A1 expression and the number of tumor infiltrating Vδ2 T cells in CRC were performed by automatic immunostaining, whole slide scanning and computerized analysis of digital pathology imaging. Results The novel ADC Cet-ZA was generated with a drug antibody ratio of 4.3 and displayed a reactivity similar to the unconjugated antibody. More importantly, patient-derived CRC organoids, or CRC tumor cell suspensions, could trigger the expansion of Vδ2 T cells from peripheral blood and tumor infiltrating lymphocytes when primed with Cet-ZA. Furthermore, Cet-ZA triggered Vδ2 T cell-mediated killing of CRC organoids. The expression of BTN3A1 and BTN2A1 was detected not only in CRC organoids but also in CRC specimens, together with a considerable amount of tumor infiltrating Vδ2 T cells. Conclusions These findings are proof of concept that the Cet-ZA ADC can be used to target specifically CRC organoids and may suggest a new experimental approach to deliver aminobisphosphonates to EGFR + solid tumors." @default.
- W4312129693 created "2023-01-04" @default.
- W4312129693 creator A5009806545 @default.
- W4312129693 creator A5018407460 @default.
- W4312129693 creator A5020528458 @default.
- W4312129693 creator A5025457197 @default.
- W4312129693 creator A5045982942 @default.
- W4312129693 creator A5051544577 @default.
- W4312129693 creator A5057394659 @default.
- W4312129693 creator A5084431015 @default.
- W4312129693 date "2022-12-01" @default.
- W4312129693 modified "2023-10-05" @default.
- W4312129693 title "Targeting of colorectal cancer organoids with zoledronic acid conjugated to the anti-EGFR antibody cetuximab" @default.
- W4312129693 cites W1107917109 @default.
- W4312129693 cites W1483496013 @default.
- W4312129693 cites W1496798385 @default.
- W4312129693 cites W1535397761 @default.
- W4312129693 cites W1566936636 @default.
- W4312129693 cites W1601232563 @default.
- W4312129693 cites W1741548448 @default.
- W4312129693 cites W1907053720 @default.
- W4312129693 cites W1934094702 @default.
- W4312129693 cites W1984111577 @default.
- W4312129693 cites W1995930566 @default.
- W4312129693 cites W1996698191 @default.
- W4312129693 cites W2002513358 @default.
- W4312129693 cites W2005323388 @default.
- W4312129693 cites W2012235549 @default.
- W4312129693 cites W2021296394 @default.
- W4312129693 cites W2024520647 @default.
- W4312129693 cites W2024883068 @default.
- W4312129693 cites W2030702295 @default.
- W4312129693 cites W2046245027 @default.
- W4312129693 cites W2049491375 @default.
- W4312129693 cites W2084223858 @default.
- W4312129693 cites W2108829078 @default.
- W4312129693 cites W2114915759 @default.
- W4312129693 cites W2123050706 @default.
- W4312129693 cites W2129229830 @default.
- W4312129693 cites W2139403967 @default.
- W4312129693 cites W2146143139 @default.
- W4312129693 cites W2162391015 @default.
- W4312129693 cites W2265419075 @default.
- W4312129693 cites W2403458189 @default.
- W4312129693 cites W2403475582 @default.
- W4312129693 cites W2409813196 @default.
- W4312129693 cites W2471940455 @default.
- W4312129693 cites W2484388069 @default.
- W4312129693 cites W2569435104 @default.
- W4312129693 cites W2588118089 @default.
- W4312129693 cites W2597045666 @default.
- W4312129693 cites W2627051037 @default.
- W4312129693 cites W2734735597 @default.
- W4312129693 cites W2780122134 @default.
- W4312129693 cites W2799763484 @default.
- W4312129693 cites W2905447079 @default.
- W4312129693 cites W2998636884 @default.
- W4312129693 cites W3048916138 @default.
- W4312129693 cites W3081865957 @default.
- W4312129693 cites W3118837964 @default.
- W4312129693 cites W3162216940 @default.
- W4312129693 cites W3181911076 @default.
- W4312129693 cites W3185273357 @default.
- W4312129693 cites W3185619265 @default.
- W4312129693 cites W3216020296 @default.
- W4312129693 cites W4280634903 @default.
- W4312129693 doi "https://doi.org/10.1136/jitc-2022-005660" @default.
- W4312129693 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36543375" @default.
- W4312129693 hasPublicationYear "2022" @default.
- W4312129693 type Work @default.
- W4312129693 citedByCount "4" @default.
- W4312129693 countsByYear W43121296932023 @default.
- W4312129693 crossrefType "journal-article" @default.
- W4312129693 hasAuthorship W4312129693A5009806545 @default.
- W4312129693 hasAuthorship W4312129693A5018407460 @default.
- W4312129693 hasAuthorship W4312129693A5020528458 @default.
- W4312129693 hasAuthorship W4312129693A5025457197 @default.
- W4312129693 hasAuthorship W4312129693A5045982942 @default.
- W4312129693 hasAuthorship W4312129693A5051544577 @default.
- W4312129693 hasAuthorship W4312129693A5057394659 @default.
- W4312129693 hasAuthorship W4312129693A5084431015 @default.
- W4312129693 hasBestOaLocation W43121296931 @default.
- W4312129693 hasConcept C121608353 @default.
- W4312129693 hasConcept C126322002 @default.
- W4312129693 hasConcept C153911025 @default.
- W4312129693 hasConcept C159654299 @default.
- W4312129693 hasConcept C185592680 @default.
- W4312129693 hasConcept C203014093 @default.
- W4312129693 hasConcept C2779998722 @default.
- W4312129693 hasConcept C502942594 @default.
- W4312129693 hasConcept C526805850 @default.
- W4312129693 hasConcept C71924100 @default.
- W4312129693 hasConcept C86803240 @default.
- W4312129693 hasConceptScore W4312129693C121608353 @default.
- W4312129693 hasConceptScore W4312129693C126322002 @default.
- W4312129693 hasConceptScore W4312129693C153911025 @default.
- W4312129693 hasConceptScore W4312129693C159654299 @default.
- W4312129693 hasConceptScore W4312129693C185592680 @default.